Abstract Details
|
Shibani S. Mukerji, MD, PhD
(Massachusetts General Hospital)
PRESENTER |
Dr. Mukerji has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. Dr. Mukerji has or had stock in Gilead Science.Dr. Mukerji has or had stock in Ranpack.Dr. Mukerji has or had stock in Snowflake. An immediate family member of Dr. Mukerji has or had stock in Amgen. The institution of Dr. Mukerji has received research support from NIH. The institution of Dr. Mukerji has received research support from Massachusetts General Hospital. |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Dana H. Gabuzda, MD (Dana-Farber Cancer Inst.) | Dr. Gabuzda has nothing to disclose. |